Adverum Biotechnologies | 10-Q: Q3 2024 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones
Adverum Biotechnologies | 10-Q: Q2 2024 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
Adverum Biotechnologies | 10-Q: Q1 2024 Earnings Report
Adverum Biotechnologies | 10-K: FY2023 Annual Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
Adverum Biotechnologies | 10-Q: Q3 2023 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
Adverum Biotechnologies | 10-Q: Q2 2023 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results
Adverum Biotechnologies | 10-Q: Q1 2023 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports First Quarter 2023 Financial Results
Adverum Biotechnologies | 10-K: FY2022 Annual Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
Adverum Biotechnologies | 10-Q: Q3 2022 Earnings Report
Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Third Quarter 2022 Financial Results
Adverum Biotechnologies | 10-Q: Q2 2022 Earnings Report
Adverum Biotechnologies | 10-Q: Q1 2022 Earnings Report
No Data